Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Horus for Pharmaceutical Industries is a leading Egyptian pharmaceutical manufacturer and a core industrial subsidiary of the EVA Pharma Group. Based in the 6th of October City, the company operates large-scale, state-of-the-art facilities dedicated to the production of high-quality generic human medicines and specialized veterinary vaccines. Its product portfolio includes oral anticoagulants such as Repatoxaban (rivaroxaban), antivirals like Avipiravir (favipiravir), and various animal health biologics produced at its dedicated Horus Vet Vaccine Factory. The company is recognized for its adherence to international manufacturing standards, including GMP, and plays a critical role in EVA Pharma's mission to enhance healthcare access across the Middle East and Africa. Through its advanced manufacturing capabilities, Horus for Pharmaceutical Industries supports the regional supply of essential medications for both human and veterinary health sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Horus for Pharmaceutical Industries.